NYSEARCA:PJP Invesco Pharmaceuticals ETF (PJP) Price, Holdings, & News $84.45 +0.57 (+0.68%) As of 04/2/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock About Invesco Pharmaceuticals ETF (NYSEARCA:PJP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PJP alerts:Sign Up Key Stats Today's Range$83.45▼$84.4550-Day Range$83.87▼$87.3352-Week Range$75.33▼$89.87Volume3,306 shsAverage Volume8,975 shsMarket Capitalization$255.88 millionAssets Under Management$253.50 millionDividend Yield1.08%Net Expense Ratio0.57%Aggregate RatingModerate Buy ETF OverviewPowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.Read More… Remove Ads Invesco Pharmaceuticals ETF ExpensesTypePJPHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.50%0.57%0.56%0.51%0.53%Other Expenses0.07%0.30%0.49%0.57%0.52%Total Expense0.57%0.70%0.72%0.73%0.71%Fee Waiver0.00%-0.45%-0.50%-0.66%-0.55%Net Expense0.57%0.61%0.63%0.58%0.60% Receive PJP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address PJP ETF News HeadlinesPJP: Big Pharma Concentration Risks Amid Looming Confirmation Of RFK Jr.December 26, 2024 | seekingalpha.comHow Is Merck's Stock Performance Compared to Other Pharmaceuticals Stocks?December 6, 2024 | msn.comDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.April 3, 2025 | Altimetry (Ad)Invesco Dynamic Pharmaceuticals ETF declares quarterly distribution of $0.2004September 24, 2024 | msn.comInvesco Pharmaceuticals ETF (PJP)August 25, 2024 | finance.yahoo.comClosing Bell: Invesco FTSE RAFI US Idx ETF down on Monday (PXU-F)August 10, 2024 | theglobeandmail.comSee More Headlines PJP ETF - Frequently Asked Questions How have PJP shares performed this year? Invesco Pharmaceuticals ETF's stock was trading at $82.62 at the start of the year. Since then, PJP shares have increased by 2.2% and is now trading at $84.45. View the best growth stocks for 2025 here. How do I buy shares of Invesco Pharmaceuticals ETF? Shares of PJP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Invesco Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Pharmaceuticals ETF investors own include NVIDIA (NVDA), Meta Platforms (META), Walt Disney (DIS), Affirm (AFRM), Advanced Micro Devices (AMD), Netflix (NFLX) and Pfizer (PFE). Fund Details IssuerInvesco Fund NameInvesco Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PJP Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser Webwww.invescopowershares.com Phone+1-800-9830903Fund Focus Asset ClassEquity BenchmarkDynamic Pharmaceutical Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings33 Fund Statistics Assets Under Management$253.50 million Average Daily Volume$4,796.70 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerCitadel Options OptionableN/A Short Interest6,400 shs Miscellaneous Outstanding Shares3,030,000Beta0.56 Creation Unit10,000 Creation Fee$500.00 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Top 10 PJP HoldingsAbbVie (NYSE:ABBV)Holding Weight: 5.18%Merck & Co., Inc. (NYSE:MRK)Holding Weight: 5.10%Amgen (NASDAQ:AMGN)Holding Weight: 5.03%Johnson & Johnson (NYSE:JNJ)Holding Weight: 4.97%Pfizer (NYSE:PFE)Holding Weight: 4.94%Eli Lilly and Company (NYSE:LLY)Holding Weight: 4.84%Gilead Sciences (NASDAQ:GILD)Holding Weight: 4.83%Abbott Laboratories (NYSE:ABT)Holding Weight: 4.73%Tarsus Pharmaceuticals (NASDAQ:TARS)Holding Weight: 3.49%ANI Pharmaceuticals (NASDAQ:ANIP)Holding Weight: 3.33%Full Holdings DetailsPJP Sector ExposurePJP Industry Exposure This page (NYSEARCA:PJP) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.